Kyung-Pil Ko

University of Melbourne — Australia

Medicine · Health Sciences

33h-index5.7kcitations138works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peptidase Inhibition and Analysis(55), Chromatin Remodeling and Cancer(49), Cancer Mechanisms and Therapy(39), Lung Cancer Research Studies(26), RNA modifications and cancer(13)

Publications137 total

SMARCA4 Loss Promotes Late-Stage Tumor Progression in Nonneuroendocrine Small Cell Lung Cancer
Molecular Cancer Research·2026Open Access
Investigating biomarkers of response to immunotherapy in small cell lung cancer
Vivli·2025Open Access
Benchmarking long-read RNA-sequencing technologies with <i>LongBench:</i> a cross-platform reference dataset profiling cancer cell lines with bulk and single-cell approaches
2025· 4 citedOpen Access
γδ T cells modulate anti-tumor immunity in small cell lung cancer
2025· 1 citedOpen Access
Lung cancer biobanking in Australia: challenges and future directions
The Medical Journal of Australia·2025· 1 citedOpen Access
Inhibition of the minor spliceosome restricts the growth of a broad spectrum of cancers
EMBO Reports·2025· 3 citedOpen Access
SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer
2025· 1 citedOpen Access
A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesis
Journal of Thrombosis and Haemostasis·2025· 2 citedOpen Access
Breathing new insights into the role of mutant p53 in lung cancer
Oncogene·2024· 22 citedOpen Access
Supplementary Table S2 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Supplementary Table S4 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Supplementary Table S4 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Supplementary Table S7 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Figure 3 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Supplementary Figure S3 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Data from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Supplementary Table S6 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Supplementary Figure S5 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Supplementary Table S3 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
Supplementary Table S8 from Molecular and Pathologic Characterization of YAP1-Expressing Small Cell Lung Cancer Cell Lines Leads to Reclassification as SMARCA4-Deficient Malignancies
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Jane E. Visvader(12), Sarah A. Best(12), Ariena Kersbergen(11), Geoffrey J. Lindeman(10), Marie-Liesse Asselin-Labat(8), Anton Berns(8), Natalie Proost(7), Ji‐Ying Song(6), Andreas Strasser(5), Warren S. Alexander(4), Matthew E. Ritchie(4), Marco J. Herold(4), Marian L. Burr(3), Sergio Wittlin(3), Vivek Rathi(3), Jackson A. McDonald(3), Clare E. Weeden(3), Mark Shackleton(2), Natasha C. Forrest(2), Lynne Hartley(2)